Home
| Welcome to Contract Pharma
June 2013 Issue
Last Updated Wednesday, June 19 2013
All
Featured Articles
News
Search Contract Pharma
Try:
adaptive
,
expiration
Subscribe Free
•
Magazine
•
eNewsletter
Magazine
Current Issue
Issue Archive
Subscribe Now
Advertise
Editorial Guidelines
Digital Edition
About Us
Contract Pharma Team
News
Breaking News
Features
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Columns
Editorials
Expert Opinions
Advanced Degrees
Financial Analysis
I, Mak
The Lowe Down
Managing Your Career
Pharma Beat
Preclinical Outsourcing
FDA Watch
India Report
Executive Perspective
Research
Top 10 BioPharma Companies
Top 20 Pharma Companies
Salary Survey
Outsourcing Survey
Whitepapers
Glossary
Ask The Experts
Directory
Companies
Categories
Corporate Capabilities
Topics
Classifieds
Contract Laboratory Services
Contract Manufacturing Services
For Sale/Lease
Micronization
Job Bank
Resources
Industry Events
Videos
Contract Pharma Conference
eNewsletter Archive
Conference Sessions
Provider Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
White Papers
Case Study
Jobs
View Other Mass Spectrometry companies
Alkermes
Company Overview
Brochures
Case Study
Services
White Papers
Contact Us
Request Information
Literature Request
Forward To Friend
Company RSS Feed
Alkermes Presents Positive Results from Phase 2 Clinical Study of ALKS 5461 in Major Depressive Disorder at 53rd Annual NCDEU Meeting
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
Alkermes Presents Positive Results from Phase 1 Study of ALKS 3831 as a Broad Spectrum Treatment for Schizophrenia
Alkermes’ Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care Conference
Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations
Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53rd Annual NCDEU Meeting
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013
Alkermes Elects Nancy Wysenski to Board of Directors
Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference
Alkermes Announces Positive Results from Phase 2 Clinical Study of ALKS 5461 for Major Depressive Disorder
Please visit our sister sites:
Nutraceuticals World
Coatings World
MPO
Beauty Packaging
Happi
Ink World
Label & Narrow Web
Medical Product Outsourcing
Nonwovens Industry
Orthopedic Design & Technology
Printed Electronics Now
Subscribe to a Magazine:
Nutraceuticals World
Coatings World
Beauty Packaging
Happi
Ink World
Label & Narrow Web
Medical Product Outsourcing
Nonwovens Industry
Orthopedic Design & Technology
Printed Electronics Now
Subscribe to eNewsletter:
Nutraceuticals World
Coatings World
MPO
Beauty Packaging
Happi
Ink World
Label & Narrow Web
Medical Product Outsourcing
Nonwovens Industry
Orthopedic Design & Technology
Printed Electronics Now
Company RSS Feed
